Key facts
- Impruvon Health’s last known valuation is $13.0M (Feb 2025).
- It has raised $6.5M; the latest was Seed Round ($2.4M) in Feb 2025.
- Notable investors include TEDCO, Virginia Innovation Partnership Corporation, Virginia Venture Partners, Dingman Center Angels, Ford Street Ventures — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Impruvon Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Impruvon Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Impruvon Health
Developer of a medical technology platform designed for automated medication management. The company's platform provides smart alerts, reminders, live notifications of unauthorized access attempts, and customized notifications tailored to each individual's needs, enabling healthcare providers to prevent medications from falling into the wrong hands.
- Sector
- Healthcare
- HQ
- Baltimore, MD, United States
- Founded
- 2020
- Employees
- 32
- Website
- impruvonhealth.com/
- Ownership
- Privately Held (backing)
Impruvon Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Impruvon Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Impruvon Health in its N-PORT filings yet. We sweep new filings monthly.